missing translation for 'onlineSavingsMsg'
Learn More

CD30/TNFRSF8 Antibody (Ber-H8) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Bio-Techne NBP3-09139

Product Code. 18317653

  • £324.00 / 0.10mg

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.
Specifications

Specifications

CD30/TNFRSF8
Monoclonal
1 mg/ml
Flow Cytometry 1-4 ug/ml, Immunohistochemistry-Paraffin 5-10 ug/ml, Immunohistochemistry-Frozen 5-10 ug/ml
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen from CD30/TNFRSF8
0.1 mg
Apoptosis, B Cell Development and Differentiation Markers, Cell Cycle and Replication, Immunology, Stem Cell Markers
943
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG1 κ
Flow Cytometry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen)
Ber-H8
Unconjugated
PBS
Mouse
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.